Sodium channel protein type 2 subunit alpha (NaV1.2) (NaV1.2)

The Sodium channel protein type 2 subunit alpha (NaV1.2), encoded by the SCN2A gene, is a voltage-gated ion channel essential for the generation and propagation of action potentials in the central nervous system (UniProt P35498; NCBI Gene 6326). It is primarily expressed in the axon initial segments of excitatory neurons, where it plays a pivotal role in regulating neuronal firing patterns (Sanders et al., 2018). Extracellular site-3, also known as neurotoxin receptor site 3, is a distinct pharmacological region located on the extracellular loops of the voltage-sensing domain of domain IV (DIV-S3-S4) (Catterall, 2000). This site is the specific target for alpha-scorpion toxins and sea anemone toxins, which bind to impede the downward movement of the DIV voltage sensor, thereby slowing the fast inactivation of the channel and increasing sodium current (Rogers et al., 1996). Clinically, NaV1.2 is a major therapeutic target; gain-of-function mutations are associated with early-infantile epileptic encephalopathy, while loss-of-function mutations are linked to autism spectrum disorder and intellectual disability (Ben-Shalom et al., 2017). Current pharmacological interventions primarily utilize sodium channel blockers like phenytoin and carbamazepine to manage hyperexcitability, though research into site-specific modulators targeting the voltage-sensing domains continues to evolve (Catterall, 2012). Targeting site-3 specifically offers a mechanism to modulate channel kinetics rather than simply blocking the pore, which may provide more nuanced control over neuronal excitability in certain disease states.

Other names

SCN2ASodium channel protein brain II subunit alphaHBSC IINAC2HBAVoltage-gated sodium channel type II alphaNeurotoxin receptor site 3NaV1.2 site-3

Modulation of channel inactivation through binding to the extracellular loops of the voltage-sensing domain in domain IV (Site-3)